TJ Biotech Invest ApS — Credit Rating and Financial Key Figures

CVR number: 44423472
Pile Alle 20, Øverød 2840 Holte

Income statement (kDKK)

2023
2024
Fiscal period length1212
Net sales
Gross profit- 197.69- 153.45
EBIT- 197.69- 153.45
Other financial income49.75102.47
Other financial expenses- 106 536.25- 260.04
Pre-tax profit- 106 684.19- 311.03
Net earnings- 106 684.19- 311.03

Assets (kDKK)

2023
2024
Intangible assets total
Tangible assets total
Investments total
Non-current loans receivable12 828.9612 570.55
Non-current other receivables4 040.004 197.35
Long term receivables total16 868.9616 767.90
Inventories total
Current other receivables925.36943.87
Short term receivables total925.36943.87
Cash and bank deposits254.5727.72
Cash and cash equivalents254.5727.72
Balance sheet total (assets)18 048.9017 739.49

Equity and liabilities (kDKK)

2023
2024
Share capital40.0040.00
Retained earnings124 668.0917 983.90
Profit of the financial year- 106 684.19- 311.03
Shareholders equity total18 023.9017 712.87
Non-current liabilities total
Current trade creditors25.0025.00
Other non-interest bearing current liabilities1.62
Current liabilities total25.0026.62
Balance sheet total (liabilities)18 048.9017 739.49
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.